Stockreport

Johnson & Johnson posts Q3 beat; lowers earnings guidance amid M&A impact [Seeking Alpha]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF J&J ( JNJ ) cut its adjusted operational earnings guidance for 2024 to $9.91 per share from $10.05 at the midpoint, noting that the impact from its recent acquisition o [Read more]